Reversal of experimental neuropathic pain by T-type calcium channel blockers

Pain

Volumn 105, Issue 1-2, 2003, Pages 159-168

  Dogrul, Ahmet ^a   Gardell, Luis R ^b   Ossipov, Michael H ^b   Tulunay, F Cankat ^c   Lai, Josephine ^b   Porreca, Frank ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b UNIVERSITY OF ARIZONA   (United States)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Neuropathic pain; Rat; T type voltage sensing calcium channels

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL T TYPE; ETHOSUXIMIDE; MIBEFRADIL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; FOOT SOLE; INJECTION; LUMBAR SPINE; MALE; NERVE INJURY; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL NERVE; SURGICAL TECHNIQUE; TACTILE STIMULATION; THERMAL STIMULATION;

EID: 0141850350     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(03)00177-5     Document Type: Article

References (60)

1. Amir R., Michaelis M., Devor M. Burst discharge in primary sensory neurons: triggered by subthreshold oscillations, maintained by depolarizing afterpotentials. J Neurosci. 22:2002;1187-1198.
2. Anwyl R. Modulation of vertebrate neuronal calcium channels by transmitters. Brain Res Brain Res Rev. 16:1991;265-281.
3. Bertolino M., Llinas R.R. The central role of voltage-activated and receptor-operated calcium channels in neuronal cells. Annu Rev Pharmacol Toxicol. 32:1992;399-421.
4. Burgess S.E., Gardell L.R., Ossipov M.H., Malan T.P. Jr, Vanderah T.W., Lai J., Porreca F. Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. J Neurosci. 22:2002;5129-5136.
5. Carbone E., Lux H.D. A low voltage-activated calcium conductance in embryonic chick sensory neurons. Biophys J. 46:1984;413-418.
6. Carbone E., Lux H.D. A low voltage-activated fully inactivating Ca channel in vertebrate sensory neurones. Nature. 310:1984;501-502.
7. 2+ channels. Annu Rev Cell Dev Biol. 16:2000;521-555.
8. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 53:1994;55-63.
9. Chaplan S.R., Pogrel J.W., Yaksh T.L. Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J Pharmacol Exp Ther. 269:1994;1117-1123.
10. Chemin J., Monteil A., Perez-Reyes E., Bourinet E., Nargeot J., Lory P. Specific contribution of human T-type calcium channel isotypes (alpha(1G), alpha(1H) and alpha(1I)) to neuronal excitability. J Physiol. 540:2002;3-14.
11. 2+ channels and heart failure. Proc Assoc Am Physicians. 111:1999;429-437.
12. Coderre T.J., Katz J., Vaccarino A.L., Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 52:1993;259-285.
13. Coulter D.A., Huguenard J.R., Prince D.A. Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons. Ann Neurol. 25:1989;582-593.
14. Devor M., Seltzer Z. Pathophysiology of damaged nerves in relation to chronic pain. Wall P.D., Melzack R. Textbook of pain. 1999;129-164 Churchill Livingstone, London.
15. Dixon W.J. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol. 20:1980;441-462.
16. Dogrul A., Yesilyurt O., Deniz G., Isimer A. Analgesic effects of amlodipine and its interaction with morphine and ketorolac-induced analgesia. Gen Pharmacol. 29:1997;839-845.
17. Dogrul A., Yesilyurt O., Isimer A., Guzeldemir M.E. L-type and T-type calcium channel blockade potentiate the analgesic effects of morphine and selective mu opioid agonist, but not to selective delta and kappa agonist at the level of the spinal cord in mice. Pain. 93:2001;61-68.
18. Dogrul A., Zagli U., Tulunay F.C. The role of T-type calcium channels in morphine analgesia, development of antinociceptive tolerance and dependence to morphine, and morphine abstinence syndrome. Life Sci. 71:2002;725-734.
19. 2+ channels. Trends Pharmacol Sci. 18:1997;37-42.
20. 2+ channels and pharmacological blockade: potential pathophysiological relevance. Cardiovasc Drugs Ther. 11:1997;723-739.
21. V1.8 in uninjured axons enables neuropathic pain. J Neurosci. 23:2003;158-166.
22. Gold M.S., White D.M., Ahlgren S.C., Guo M., Levine J.D. Catecholamine-induced mechanical sensitization of cutaneous nociceptors in the rat. Neurosci Lett. 175:1994;166-170.
23. Gracely R.H., Lynch S.A., Bennett G.J. Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain. 51:1992;175-194.
24. Han H.C., Lee D.H., Chung J.M. Characteristics of ectopic discharges in a rat neuropathic pain model. Pain. 84:2000;253-261.
25. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
26. Hermsmeyer K., Mishra S., Miyagawa K., Minshall R. Physiologic and pathophysiologic relevance of T-type calcium-ion channels: potential indications for T-type calcium antagonists. Clin Ther. 19:(Suppl A):1997;18-26.
27. Huguenard J.R. Low-threshold calcium currents in central nervous system neurons. Annu Rev Physiol. 58:1996;329-348.
28. Jimenez C., Bourinet E., Leuranguer V., Richard S., Snutch T.P., Nargeot J. Determinants of voltage-dependent inactivation affect mibefradil block of calcium channels. Neuropharmacology. 39:2000;1-10.
29. Kajander K.C., Bennett G.J. Onset of a painful peripheral neuropathy in rat: a partial and differential deafferentation and spontaneous discharge in A beta and A delta primary afferent neurons. J Neurophysiol. 68:1992;734-744.
30. 2+ concentration in the spinal dorsal horn in an animal model of neuropathic pain. Pain. 68:1996;85-96.
31. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363.
32. Kostyuk P.G., Molokanova E.A., Pronchuk N.F., Savchenko A.N., Verkhratsky A.N. Different action of ethosuximide on low- and high-threshold calcium currents in rat sensory neurons. Neuroscience. 51:1992;755-758.
33. Lai J., Gold M.S., Kim C., Bian D., Ossipov M.H., Hunter J.C., Porreca F. Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, Nav1.8. Pain. 95:2002;143-152.
34. 2+ channel beta subunit depletion in nodosus ganglion neurons. J Neurosci. 17:1997;6621-6628.
35. 2+ currents are generated by members of the CavT subunit family (alpha1G/H) in rat primary sensory neurons. J Neurosci. 18:1998;8605-8613.
36. Liu X., Eschenfelder S., Blenk K.H., Janig W., Habler H. Spontaneous activity of axotomized afferent neurons after L5 spinal nerve injury in rats. Pain. 84:2000;309-318.
37. 2+ influx into the dendrites of hippocampal pyramidal neurons. J Neurophysiol. 74:1995;1335-1342.
38. Markram H., Sakmann B. Calcium transients in dendrites of neocortical neurons evoked by single subthreshold excitatory postsynaptic potentials via low-voltage-activated calcium channels. Proc Natl Acad Sci USA. 91:1994;5207-5211.
39. 2+) channel blocker, on dorsal horn neuronal responses in rats. Eur J Pharmacol. 415:2001;141-149.
40. Matthews E.A., Dickenson A.H. Effects of spinally delivered N- and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain. 92:2001;235-246.
41. 2+ channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat. Eur J Pharmacol. 352:1998;189-197.
42. Miljanich G.P., Ramachandran J. Antagonists of neuronal calcium channels: structure, function, and therapeutic implications. Annu Rev Pharmacol Toxicol. 35:1995;707-734.
43. Millan M.J. The induction of pain: an integrative review. Prog Neurobiol. 57:1999;1-164.
44. Monteil A., Chemin J., Bourinet E., Mennessier G., Lory P., Nargeot J. Molecular and functional properties of the human alpha(1G) subunit that forms T-type calcium channels. J Biol Chem. 275:2000;6090-6100.
45. Nebe J., Ebersberger A., Vanegas H., Schaible H.G. Effects of omega-agatoxin IVA, a P-type calcium channel antagonist, on the development of spinal neuronal hyperexcitability caused by knee inflammation in rats. J Neurophysiol. 81:1999;2620-2626.
46. Perez-Reyes E., Cribbs L.L., Daud A., Lacerda A.E., Barclay J., Williamson M.P., Fox M., Rees M., Lee J.H. Molecular characterization of a neuronal low-voltage-activated T-type calcium channel. Nature. 391:1998;896-900.
47. Perney T.M., Hirning L.D., Leeman S.E., Miller R.J. Multiple calcium channels mediate neurotransmitter release from peripheral neurons. Proc Natl Acad Sci USA. 83:1986;6656-6659.
48. Porreca F., Ossipov M.H., Gebhart G.F. Chronic pain and medullary descending facilitation. Trends Neurosci. 25:2002;319-325.
49. Rasband M.N., Park E.W., Vanderah T.W., Lai J., Porreca F., Trimmer J.S. Distinct potassium channels on pain-sensing neurons. Proc Natl Acad Sci USA. 98:2001;13373-13378.
50. Schild J.H., Kunze D.L. Experimental and modeling study of Na+ current heterogeneity in rat nodose neurons and its impact on neuronal discharge. J Neurophysiol. 78:1997;3198-3209.
51. Sekizawa S.I., French A.S., Torkkeli P.H. Low-voltage-activated calcium current does not regulate the firing behavior in paired mechanosensory neurons with different adaptation properties. J Neurophysiol. 83:2000;746-753.
52. Sheen K., Chung J.M. Signs of neuropathic pain depend on signals from injured nerve fibers in a rat model. Brain Res. 610:1993;62-68.
53. Todorovic S.M., Meyenburg A., Jevtovic-Todorovic V. Mechanical and thermal antinociception in rats following systemic administration of mibefradil, a T-type calcium channel blocker. Brain Res. 951:2002;336-340.
54. White D.M., Cousins M.J. Effect of subcutaneous administration of calcium channel blockers on nerve injury-induced hyperalgesia. Brain Res. 801:1998;50-58.
55. Woolf C.J., Thompson S.W. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 44:1991;293-299.
56. Xiao W.H., Bennett G.J. Synthetic omega-conopeptides applied to the site of nerve injury suppress neuropathic pains in rats. J Pharmacol Exp Ther. 274:1995;666-672.
57. Yaksh T.L., Chaplan S.R. Physiology and pharmacology of neuropathic pain. Anesthesiol Clin N Am. 15:1997;335-353.
58. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol Behav. 17:1976;1031-1036.
59. Yamamoto T., Sakashita Y. Differential effects of intrathecally administered N-, P-type voltage-sensitive calcium channel blockers upon two models of experimental mononeuropathy in the rat. Brain Res. 794:1998;329-332.
60. Yoon Y.W., Na H.S., Chung J.M. Contributions of injured and intact afferents to neuropathic pain in an experimental rat model. Pain. 64:1996;27-36.